JASKIRT CHAHAL: Open Payments
NPI 1528535036 · ROME, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,606 in 120 payments from 18 companies in 2025. Trend: 2023 $1,029 · 2024 $1,191 · 2025 $2,606
Food & beverage: $1,846Speaker / faculty: $675Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $1,066 |
| Janssen Biotech, Inc. | 12 | $301 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $289 |
| QOL Medical, LLC | 10 | $187 |
| Ardelyx, Inc. | 12 | $177 |
| VIVUS LLC | 6 | $108 |
| Madrigal Pharmaceuticals | 5 | $78 |
| PFIZER INC. | 3 | $56 |
| Lilly USA, LLC | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
Products named: CREON, TREMFYA, XIFAXAN, Sucraid, IBSRELA, LINZESS, RINVOQ, REZDIFFRA.
Industry payments across NY — which companies pay providers there.
